This article explores the evolving landscape of Market Access for Advanced Therapy Medicinal Products (AMTPs).

Patient registries are the backbone of clinical research and development. This article explains how they are essential in understanding how individual therapies work and getting them approved by regulatory agencies, especially for Cell and Gene Therapies. What is a...

 In this blog post, we discuss the role of multidisciplinary discussion in the early diagnosis of Interstitial lung disease in patients with Autoimmune Rheumatic Diseases. From doctors to therapists, the use of a multitude of professionals is essential when it comes...

Gene therapies offer new opportunities for the treatment of orphan diseases and chronic diseases, for which limited, or no effective treatment options are available. However, the novelty and complexity associated with gene therapies and other advanced therapy...

What is Market Access? Market Access focuses on enabling patients to access treatments beneficial to their health. When a treatment ultimately survives the long process of getting approval to go to the market, there is still no guarantee that that treatment will reach...

Learn how to use Patient Reported Outcomes in Clinical Practice in the webinar replay; Applications, challenges & guidelines.

What is Market Access? When learning how to use Discrete Choice Experiments, first we have to look at the bigger picture. Market Access focuses on enabling patients to access treatments beneficial to their health. When a treatment finally survived the long and tedious...

Insights on the importance of understanding and researching the unmet medical needs for patients with Epidermolysis Bullosa.

In this webinar, ISHEO and AREX Advisor focused on presenting an overview of how different EU countries apply Evidence Synthesis to provide a compass and help professionals navigate the sea of ​​uncertainty created by the vast set of studies present today. Together,...